Management
Prof. Michael Joner
In recent years, modern interventional techniques for the treatment of valvular heart disease have been introduced at the Department of Cardiovascular Diseases. These new, minimally invasive procedures include:
- Transcatheter aortic valveHeart valve between the left ventricle and the aorta. It prevents the blood from flowing back into the left ventricle during the relaxation phase. implantation (TAVI): a severe narrowing of the aortic valveValve. is dilated via the groin or via the apex of the heart and a new heart valveIn the inflow and outflow area of the heart chambers there are valves which prevent the blood from flowing back in the wrong direction. Each heart half has a sail valve and a pocket valve: 1. Tricuspid valve (between the right atrium and right ventricle) 2. Pulmonary valve (between the right ventricle and pulmonary artery) 3. Mitral valve (between the left atrium and left ventricle) 4. Aortic valve (between the left ventricle and the aorta). is inserted.
- MitraClip procedure: a high-grade leak in the mitral valveHeart valve between the left atrium and left ventricle. It got its name because of its shape, which has a strong resemblance to a bishop’s mitre. is sealed with one or more clips (MitralClips).
- Atrial appendage closure: a new therapy to reduce the risk of stroke for patients with atrial fibrillation and severe side effects (bleeding) on blood thinning drug therapy (e.g. Marcumar) is the closure of the left atrial appendage using an Amplatzer™ Cardiac Plug (ACP).
An essential task of the special outpatient clinic is the assessment of patients who are to receive a TAVI, a MitraClip or an atrial appendage closure as well as their professional follow-up care. In many cases, a preliminary assessment of the underlying valve disease, an evaluation of the severity and the overall condition and concomitant diseases of the patient as well as an individual planning of the further procedure is possible right from the first examination, as well as the provision of a second opinion for referring doctors or patients.
Among the outstanding advantages for the treatment of severe heart valve defects at the German Heart Centre Munich are the
- very close cooperation between cardiologists and cardiac surgeons,
- joint staffing of the clinics,
- interdisciplinary heart valve conference held at least once a week.
When determining the indication, we follow the guidelines of the European and German Society of Cardiology.
In patients with atrial fibrillation, systemic and especially cerebrovascular embolismSmall particles washed away with the bloodstream (= embolus, usually parts of blood clots from another part of the circulatory system) can cause blood vessels to close. As a result, the cells supplied by the blood vessel in question die. Air, fat and foreign bodies that get into the vessels can also cause an embolism. with insult is the most serious complication. If bleeding occurs on standard oral anticoagulationInhibition of blood clotting by means of medication (e.g. Marcumar, Heparin). Colloquially also incorrectly referred to as “blood thinning”. therapy, it is possible to close the left atrial appendage, where more than 90 per cent of the thrombi in atrial fibrillation originate, with an Amplatzer Cardiac Plug (St. Jude Medical). This treatment method has been carried out at the German Heart Centre Munich since 2011 and is an alternative to long-term oral anticoagulation for these patients.